Date: Tuesday 3 February
Time: 1:00 – 2:00pm
Topic: Treatment options in Mesothelioma
Speaker: A/Professor Anthony Linton, Medical Oncologist and ADDRI Academic and Research Director
Platform: Microsoft Teams: Once you register, you will receive an email with the Teams link and joining instructions prior to the session.
What to expect on the day:
Please note: the presentation will be recorded and made available on the ADDRI website the next day.
For any questions or further information, please contact Jennifer Coles via email or phone: (02) 9767 9811.
Academic and Research Director
Dr Linton is a senior staff specialist in medical oncology at the Concord Cancer Centre in Concord Repatriation General Hospital, specialising in thoracic, genitourinary and brain malignancies. Dr Linton received his medical degree at the University of New South Wales before completing physician and oncology training at Concord Repatriation General Hospital.
He has been associated with the Asbestos and Dust Diseases Research Institute since 2011, when he joined as the first Biaggio Signorelli Fellow and completed his PhD at ADDRI investigating prognostic factors and new therapeutic targets in malignant pleural mesothelioma. He continued to collaborate with ADDRI researchers in translational research projects as an expert advisor and in 2024 was appointed the academic and research director of the institute.
He has published widely in international peer reviewed journals and he has presented on mesothelioma and other thoracic malignancies at national and international meetings. Dr Linton is a principal investigator on a number of clinical trials and is passionate regarding the translation of research from the laboratory to the clinic.
Dr Linton has a keen interest in education and training, previously serving as network director of physician training at the Concord Hospital Network, and is an A/Professor at the University of Sydney.
Meso Hour is an initiative of the Commonwealth Mesothelioma Alliance, made possible by the Biaggio Signorelli Foundation.
